Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02929212 · ClinicalTrials.gov registry record · NA
Effect of Number of Meals on Metabolism After Weight Loss Surgery
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02929212: Completed NA study, sponsored by Columbia University.
NCT02929212 is a NA study that has completed, run by Columbia University. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02929212, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of meal size and texture on the levels of incretin hormone, GLP-1, after Gastric Bypass Surgery (GBP). Patterns of food intake change after bariatric surgery and patients often eat multiple small low-calorie meals, a pattern that may affect blood glucose as well as incretin levels. Whether the release of GLP-1 after an oral challenge or a single liquid meal has any physiological relevance in 'real life' setting of multiple small meals diet is unclear.
Primary Outcome
Investigators will assess GLP-1 levels in subjects pre and post-GBP
Interventions
- DRUG Acetaminophen
- OTHER Liquid Meal
- OTHER Solid Meal
- OTHER Single, 600 kcal meal
- OTHER Multiple, 200 kcal meals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT02929212 record still lists
NCT02929212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT02929212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02929212 about?
NCT02929212 is a clinical study titled "Effect of Number of Meals on Metabolism After Weight Loss Surgery". The purpose of this study is to determine the effect of meal size and texture on the levels of incretin hormone, GLP-1, after Gastric Bypass Surgery (GBP). Patterns of food intake change after bariatric surgery and patients often eat multiple small low-calorie meals, a pattern that may affect blood ...
What is the current status of trial NCT02929212?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-09. Estimated completion is 2014-04.
What interventions are being tested in trial NCT02929212?
The interventions under investigation include: Acetaminophen (DRUG), Liquid Meal (OTHER), Solid Meal (OTHER), Single, 600 kcal meal (OTHER), Multiple, 200 kcal meals (OTHER).
Who is sponsoring clinical trial NCT02929212?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02929212's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia